DALTIDE Trademark

Trademark Overview

On Tuesday, January 15, 2008, a trademark application was filed for DALTIDE with the United States Patent and Trademark Office. The USPTO has given the DALTIDE trademark a serial number of 77372293. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 16, 2012. This trademark is owned by Glaxo Group Limited. The DALTIDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
daltide

General Information

Serial Number77372293
Word MarkDALTIDE
Filing DateTuesday, January 15, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 16, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 23, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 18, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Tuesday, January 17, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 16, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 14, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 13, 2011EXTENSION 5 GRANTED
Friday, June 10, 2011EXTENSION 5 FILED
Friday, June 10, 2011TEAS EXTENSION RECEIVED
Saturday, October 23, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 22, 2010EXTENSION 4 GRANTED
Thursday, October 21, 2010EXTENSION 4 FILED
Thursday, October 21, 2010TEAS EXTENSION RECEIVED
Thursday, May 27, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 26, 2010EXTENSION 3 GRANTED
Monday, May 24, 2010EXTENSION 3 FILED
Monday, May 24, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 21, 2010EXTENSION 2 GRANTED
Thursday, December 3, 2009EXTENSION 2 FILED
Wednesday, January 20, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 3, 2009TEAS EXTENSION RECEIVED
Saturday, October 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 12, 2009EXTENSION 1 GRANTED
Tuesday, May 12, 2009EXTENSION 1 FILED
Tuesday, May 12, 2009TEAS EXTENSION RECEIVED
Monday, May 11, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 11, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 16, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 23, 2008PUBLISHED FOR OPPOSITION
Wednesday, September 3, 2008NOTICE OF PUBLICATION
Monday, August 18, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 18, 2008ASSIGNED TO LIE
Tuesday, August 12, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 22, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 22, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 22, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, April 27, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, April 27, 2008NON-FINAL ACTION E-MAILED
Sunday, April 27, 2008NON-FINAL ACTION WRITTEN
Monday, April 21, 2008ASSIGNED TO EXAMINER
Friday, January 18, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

daltide pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic